Pharmacokinetics and pharmacodynamics of dabigatran etexilate 75 mg BID in patients with severe chronic kidney disease - prospective validation of a post hoc determined dose
Autoren
Kooiman J, Van der Hulle T, Maas H, Wiebe S, Formella S, Clemens A, Van Buren M, Janssen M, Rabelink TJ, Huisman MV
Journal
J Am Coll Cardiol
Veröffentlichungsdatum
2016
Impact Factor
16.500
Abstract
Weitere IDs
Pharmacokinetics and pharmacodynamics of dabigatran etexilate 75 mg BID in patients with severe chronic kidney disease - prospective validation of a post hoc determined dose - Publikation von Dr. Andreas Clemens | Dr. Andreas Clemens